Discover NutraLac™
Empowering Motherhood
Nourishing Infancy.
Who We Are
Nutraceutical Technologies International, LLC
Nutraceutical Technologies International, LLC (NTI) focuses on the research and development of clinically documented nutraceutical nutritional solutions for achieving sustainable health and wellness in nutritionally at-risk populations.
Nutraceuticals comprise all-natural derivatives of plant materials that possess phytonutrients with pharmacological values beyond their natural vitamin and mineral content when enzymatically hydrolyzed. Phytonutrients are natural chemicals produced by plants that contain powerful antioxidants beneficial to human health by protecting against serious health conditions. Our patented enzyme hydrolyzation process embodies a complex of seven specific natural enzymes under precise time/temperature regimes to cleave complex, less efficacious phytonutrients into simple and highly bioavailable nutraceutical components for increased efficacy in the human digestive system. Efficacy is the capacity for beneficial change or therapeutic effect. By ‘predigesting’ these phytonutrients, the NTI enzyme hydrolyzation process enhances the human body’s ability to absorb and utilize them.
In this process, complex proteins are reduced to simple proteins (amino acids and peptides) for increased digestibility, complex fats are broken down into antioxidant-rich fats and free fatty acids, and complex carbohydrates are broken down into less complex polysaccharides for greater absorption in the intestinal tract. Compared to standard enzyme treatments, the proprietary NTI-enhanced enzyme treatment process significantly increases phytonutrient bioavailability for absorption and nutritional efficacy in the human digestive system.
Ref. U.S. Patent No. 8,945,642 B2).
| Standard Enzyme Treatment (SET) vs NTI Enhanced Enzyme Treatment (EET) |
||||
|---|---|---|---|---|
| % Solids | Dry Basis Wt. | Fat | Protein | |
| SET Extraction | 7.14 | 7.45 | 0.93 | 0.83 |
| EET Extraction | 11.41 | 12.89 | 2.50 | 2.65 |
| % Increase | 59.8% | 73.1% | 167.6% | 220.9% |
Our Mission
We are passionate about maximizing maternal and infant nutrition, empowering lactating mothers, and safeguarding the health and wellness of their breastfed infants to eradicate the devastating impacts of nutritional deficiencies.
Our priority is the nutritional wellness of lactating mothers and their breastfed infants during the critical postpartum period from birth to six months of infant life when infants’ digestive systems are not mature enough to process formulated nutritional products. It is a time when newborns are most susceptible to gastrointestinal diseases, respiratory infections, and immune system deficiencies that can create risks of diminished physical wellness, cognitive stunting, and even premature death (ref. UNICEF Global Report “From the First Hour of Life”).
NutraLac™, NTI’s clinically documented postpartum nutraceutical product, is derived from the phytonutrients embodied in the bran layer of rice. NutraLac replenishes nutrients mothers lose to pregnancy and breastfeeding and enables the transfer of bioactive phytonutrient benefits to their infants through breastmilk. NutraLac is a patented postpartum nutraceutical galactagogue. Nutraceutical galactagogues are phytonutrients with enhanced nutritional benefits known to increase breast milk supply. Our NutraLac clinical trials documented infant health and development benefits across all five World Health Organization growth matrixes.
Results of Clinical Trials where mothers took 40g of NutraLac formulation daily for 4.5 months.
| Anthropometric Indicator | Initial Z score (1.5 months old) | Final Z score (6 months old) | p-value | ||||
|---|---|---|---|---|---|---|---|
| n | mean ± st. dev. | percentile | n | mean ± st. dev. | percentile | ||
| Weight-for-height (WFH) | 153 | +0.17 ± 1.3 | 56.75 | 129 | +0.53 ± 1.0 | 70.19 | 0.00890 |
| Length-for-age (LFA) | 153 | -1.90 ± 1.21 | 2.87 | 129 | -1.78 ± 1.0 | 3.75 | 0.34730 |
| Weight-for-age (WFA) | 153 | -1.60 ± 1.3 | 5.48 | 129 | -.079 ± 1.0 | 21.48 | <0.0001 |
| Cephalic perimeter-for-age (CPFA) | 153 | -1.30 ± 1.14 | 9.68 | 129 | -1.03 ± .09 | 15.15 | 0.03140 |
| Body mass index-for-age (BMIFA) | 153 | -.82 ± 1.33 | 20.61 | 129 | +0.31 ± 1.3 | 62.17 | <0.0001 |
Mission Statement
Our Vision
Revolutionize maternal and infant nutrition, empowering mothers and safeguarding the health and development of their breastfed infants. We are driven by a commitment to eradicate the devastating impacts of malnutrition during the critical postpartum period, fostering a world where every newborn has the opportunity for a healthy and thriving start to life.
Get In Touch
We are currently evaluating investors to support a go to market strategy to successfully launch and establish the brand over a five-year plan.
Interested parties should reach us by submitting a request.